Does Anthem Cover Zepbound? Coverage Rules, Prior Authorization, and What to Do If You're Denied

Key Takeaways

• Anthem covers Zepbound on most commercial plans, but coverage is plan-specific. Some employer-sponsored Anthem plans exclude weight-loss drugs entirely.
• When covered, Zepbound is typically on Tier 3 or specialty tier and requires prior authorization with documented BMI and lifestyle intervention history.
• Typical out-of-pocket cost on Anthem ranges from $25 (with manufacturer savings card) to $500+ per month, depending on tier and deductible status.
• Anthem Medicare Advantage plans don't cover Zepbound for weight loss, since Medicare doesn't cover weight-loss medications.
• Denials are common but appealable. About 30 to 40% of first-time denials are overturned on first appeal with proper documentation.

Direct answer (40-60 words)

Anthem covers Zepbound on most commercial plans, with prior authorization and a Tier 3 or specialty copay. Coverage requires documented BMI of 30+ (or 27+ with comorbidities) and prior lifestyle intervention. Some employer plans exclude weight-loss drugs entirely. Anthem Medicare Advantage doesn't cover Zepbound for weight loss. Denials can be appealed.

Table of contents

1. The 30-second answer
2. Anthem plan types and how each handles Zepbound
3. Prior authorization criteria
4. Out-of-pocket costs by plan type
5. Anthem's exclusion language: how to read your plan
6. The denial appeal process
7. What to do if your Anthem plan excludes weight-loss drugs entirely
8. The compounded semaglutide alternative
9. FAQ
10. Sources
11. Footer disclaimers

Anthem plan types and how each handles Zepbound

Anthem operates as Anthem BlueCross BlueShield in 14 states. Coverage rules vary by plan type:

Anthem commercial plans (employer-sponsored or individual): Most cover Zepbound when prior authorization criteria are met. Specific tier varies. Common placements: Tier 3 (preferred specialty) or Tier 4 (non-preferred specialty). Copays range from $40 to $300 per fill, plus deductible.

Anthem ACA marketplace plans: Coverage exists on most Anthem marketplace plans. ACA rules require certain weight-loss treatments be covered on most plans, but the specific drug formulary placement is plan-by-plan.

Anthem Medicaid plans: State-by-state. About 12 of the 14 Anthem Medicaid states cover Zepbound for severe obesity (BMI 35+) with prior authorization. Coverage for BMI 30 to 34 is more variable.

Anthem Medicare Advantage: Does not cover Zepbound for weight loss. Federal Medicare regulations exclude coverage of drugs for weight management, regardless of which carrier administers the plan.

Anthem self-insured employer plans: Self-insured plans set their own formulary. Some cover Zepbound; others exclude weight-loss drugs as a class. Check your plan's specific summary of benefits or call the member services line to confirm.

To find your specific coverage: log into your Anthem member portal, navigate to "Pharmacy Benefits" or "Drug Search," and search for "Zepbound" or "tirzepatide." The portal will show your specific tier, copay, and PA requirements.

Prior authorization criteria

If your Anthem plan covers Zepbound, prior authorization is almost always required. The documentation needed:

Required documentation (typical):

• Body Mass Index of 30 or higher, OR BMI of 27 or higher with at least one obesity-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, sleep apnea)
• Documentation of at least 6 months of lifestyle intervention (diet and exercise) without sufficient response
• Provider attestation that the patient has been counseled on dietary and behavioral changes
• No history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
• Treatment plan including continued lifestyle counseling alongside pharmacotherapy

Anthem-specific PA criteria (subject to update):

• Initial approval typically 6 to 12 months
• Renewal requires documented weight loss of at least 5% from baseline
• If less than 5% loss in 12 weeks, the PA may not be renewed at the next review

The provider submits the PA via Anthem's electronic prior authorization system or by fax. Approval typically takes 3 to 14 days. If approved, the prescription is filled at the pharmacy at the patient's tiered copay. If denied, the patient can appeal.

A 2024 Anthem published statistic: approximately 65% of Zepbound PAs are approved on first submission. The other 35% are denied on first submission, often for incomplete documentation rather than substantive criteria failure.

Out-of-pocket costs by plan type

Realistic cost ranges on Anthem commercial plans:

With the Lilly Zepbound savings card:

• Eligible commercial plan members: as low as $25 per month
• Maximum benefit roughly $469 per month
• Limit of 12 fills per year
• Not available to Medicare, Medicaid, TRICARE, or VA patients

Without insurance or savings card:

• Walmart, CVS, Costco cash prices: $1,025 to $1,200 per month
• Lilly Direct (manufacturer direct-to-consumer for select doses): $349 to $549 per month for vial doses

For more on Zepbound costs, see our Zepbound cost guide and savings card guide.

Anthem's exclusion language: how to read your plan

Some Anthem plans, particularly self-insured employer plans, include explicit exclusion language for weight-loss medications. The phrasing to watch for in your plan's Summary of Benefits and Coverage (SBC) or detailed certificate of coverage:

"Drugs for weight loss are not covered." A blanket exclusion. Zepbound, Wegovy, Ozempic for weight loss, all excluded. Some plans with this language still cover Ozempic for type 2 diabetes (different indication, different drug coverage).

"Anti-obesity drugs are excluded." Equivalent to the above.

"Weight management programs and related medications are excluded." Often means Zepbound is excluded but covers other diabetes drugs.

"Off-label uses are not covered." Doesn't always exclude Zepbound (which is FDA-approved for weight management). But sometimes a plan interprets weight loss as outside their narrow definition of medical necessity.

If your plan has any of this language, your only paths to coverage are:

1. Switching to a plan that covers it (during open enrollment)
2. Asking your employer's HR to add coverage as a benefit (sometimes works)
3. Paying out of pocket via Lilly Direct or compounded alternatives

The denial appeal process

If Anthem denies your Zepbound PA, you have appeal rights. The process:

Step 1: Internal appeal (Level 1).

• Submit within 180 days of denial (most plans)
• Provider letter detailing medical necessity
• Supporting documentation: BMI history, comorbidity records, prior intervention history, weight loss history if any
• Anthem responds within 30 days for non-urgent appeals, 72 hours for urgent

Step 2: Internal appeal (Level 2).

• Required if Level 1 denial is upheld
• Different reviewer than Level 1
• Same documentation, with any additional clinical context
• Anthem responds within 30 days

Step 3: External appeal.

• After Level 2 denial, you can request external review by an independent third party
• Free for the patient (Anthem pays the reviewer)
• External reviewer's decision is binding on Anthem
• Typically resolved within 45 days

Common reasons for denial and counter-strategies:

A 2024 Kaiser Family Foundation report found that overall, about 33% of denied PAs are overturned on appeal. For GLP-1 medications specifically, the rate is closer to 40 to 50% with provider-supported appeals.

The single biggest predictor of successful appeal: a provider who knows the system, has a template letter, and submits comprehensive supporting documentation on the first appeal.

What to do if your Anthem plan excludes weight-loss drugs entirely

If your plan has a categorical weight-loss drug exclusion, appeals usually don't help. The exclusion is contractual, not a coverage gap. Practical options:

Option 1: Pursue coverage for a different indication. If you have type 2 diabetes, Mounjaro (same active ingredient, different brand) is approved for diabetes management. Some Anthem plans cover Mounjaro for diabetes even when they exclude Zepbound for weight loss. Discuss with your provider.

Option 2: Lilly Direct. Lilly's direct-to-consumer program offers Zepbound vial doses (2.5 mg, 5 mg, 7.5 mg, 10 mg) at $349 to $549 per month without insurance. The vial format isn't the pre-filled pen but is the same medication.

Option 3: Wait for open enrollment. If your employer offers multiple plan options, switch to one with weight-loss drug coverage. Compare formularies before enrolling.

Option 4: Compounded tirzepatide via telehealth. Compounded tirzepatide costs significantly less than brand-name Zepbound (typical $279 to $499 per month). Compounded products are not FDA-approved and aren't interchangeable with brand-name Zepbound, but they contain the same active ingredient. Compounded products are not covered by insurance.

Option 5: Patient assistance. Lilly does offer some patient assistance for low-income patients (income below 400% of federal poverty level), but the program is more limited for Zepbound than for older Lilly drugs. Contact LillyCares for current eligibility.

The choice between brand-name and compounded depends on financial situation, insurance status, and tolerance for the regulatory differences. For a deeper comparison, see our compounded vs brand-name guide.

The compounded semaglutide alternative

If Zepbound coverage isn't working and you can't justify $349+ per month for Lilly Direct, compounded semaglutide is the most common alternative.

Pricing:

• FormBlends compounded semaglutide: $179 to $279 per month
• Other major telehealth platforms: $199 to $499 per month

Differences from brand-name Zepbound:

• Compounded semaglutide is semaglutide, not tirzepatide; the molecules are different
• Semaglutide and tirzepatide produce different weight-loss outcomes; tirzepatide tends to produce more loss in head-to-head trials (SURPASS-2, Frias et al., 2021)
• Compounded semaglutide is drawn from a vial with a U-100 insulin syringe rather than delivered by a pre-filled pen
• It is not FDA-approved; it's prepared by a state-licensed compounding pharmacy in response to an individual prescription

For patients who want tirzepatide specifically, compounded tirzepatide is also available (typical $279 to $499 per month).

FAQ

Does Anthem cover Zepbound? On most commercial plans, yes, with prior authorization. On Medicare Advantage plans, no. On self-insured employer plans, it depends on the specific plan's formulary. Check your plan's Summary of Benefits and Coverage or call member services.

What's the typical Anthem copay for Zepbound? Most commercial plans place Zepbound on Tier 3 or specialty tier, with copays of $50 to $300 per fill after deductible. With the Lilly savings card, eligible commercial members pay as little as $25.

Does Anthem require prior authorization for Zepbound? Yes, almost always. The PA requires documentation of BMI, prior lifestyle intervention, and comorbidities. Approval typically takes 3 to 14 days.

What's the BMI requirement for Anthem to approve Zepbound? BMI of 30 or higher (obesity), OR BMI of 27 or higher with at least one obesity-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, sleep apnea). This matches the FDA-approved indication for Zepbound.

Does Anthem Medicaid cover Zepbound? Coverage varies by state. About 12 of 14 Anthem Medicaid states cover Zepbound for severe obesity (BMI 35+). Coverage for BMI 30 to 34 is more variable. Check your state Medicaid formulary.

Why was my Anthem Zepbound PA denied? Common reasons: BMI not documented, no prior lifestyle intervention history, missing comorbidity records, or step therapy not completed. About 35% of first-time PAs are denied, mostly for documentation issues. Appeals overturn 30 to 40% of denials.

Can I appeal an Anthem Zepbound denial? Yes. You have 180 days to file an internal appeal after a denial. If the internal appeals (Level 1 and Level 2) uphold the denial, you can request external review by an independent third party. Provider-supported appeals have higher success rates.

Does Anthem cover Mounjaro for weight loss? Mounjaro is FDA-approved for type 2 diabetes only, not for weight loss. Anthem covers Mounjaro for diabetes with PA. Off-label use for weight loss is generally not covered. Patients seeking tirzepatide for weight loss should request Zepbound (the same molecule, different brand approved for weight management).

Does Anthem cover Wegovy or Saxenda? Most Anthem commercial plans cover Wegovy and Saxenda for weight management with similar PA criteria to Zepbound. Tier placement varies; some plans prefer Wegovy over Zepbound or vice versa. Check your plan's formulary.

What if my employer's Anthem plan excludes weight-loss drugs? Your options are: switch plans at open enrollment, ask HR to add coverage as a benefit, pay out of pocket via Lilly Direct ($349 to $549/month), or use a compounded alternative ($179 to $499/month via telehealth).

Does the Lilly savings card work with Anthem? Yes, for eligible commercial Anthem members. The card reduces copays to as little as $25 per month, with a maximum benefit of approximately $469 per fill, for up to 12 fills per year. Not available to Anthem Medicare or Medicaid members.

Can I use the Lilly savings card if I have an HSA? Generally yes. The savings card is independent of HSA status. The HSA deductible may need to be met first depending on your plan's pharmacy benefit design.

Does Anthem require step therapy for Zepbound? Some Anthem plans require step therapy, meaning you must try a less expensive medication first (often phentermine or naltrexone-bupropion). Other plans allow direct access to Zepbound when PA criteria are met. Your specific plan's PA form will indicate whether step therapy is required.

Sources

1. Eli Lilly. Zepbound (tirzepatide) prescribing information, 2024 revision.
2. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216.
3. Frias JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021;385:503-515.
4. Anthem BlueCross BlueShield. National pharmacy formulary and prior authorization criteria, 2026 edition.
5. Kaiser Family Foundation. Prior authorization in commercial insurance: trends and outcomes. KFF 2024.
6. Centers for Medicare & Medicaid Services. Medicare Part D coverage of weight-loss drugs. CMS guidance, 2024.
7. American Association of Clinical Endocrinology. Comprehensive clinical practice guidelines for medical care of patients with obesity. Endocrine Practice. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Wegovy, Ozempic, and Saxenda are registered trademarks of Novo Nordisk A/S. Anthem and Anthem BlueCross BlueShield are registered trademarks of Anthem Inc. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.